Magazine Article | July 5, 2018

Sage Therapeutics — Sitting On The Brink Of CNS Breakthroughs

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

Jeff Jonas, M.D., likes to talk about “challenging conventional wisdom.” He’s also fond of similar phrases such as “changing paradigms” and “thinking differently,” all of which he utters within the first 10 minutes of our interview. He is, after all, the CEO of Sage Therapeutics, a biopharma company well-known for being unconventional in its approach to developing drugs for CNS disorders.